Industry Sponsored Symposium: Prioritizing decentralized care for HCV-infected patients: A unique opportunity for addiction medicine
| Thursday, October 14, 2021 |
| 1:15 PM - 2:15 PM |
Overview
Please join Prof. Brian Conway, Jody Gilmore, MSN, ANP-BC, and Prof. Andrew Lloyd at 1:15 PM (AEDT) / 4:15 AM (CEST) on 14th October 2021 for an engaging AbbVie-sponsored virtual symposium. The session will explore the rationale for prioritizing HCV care for people who inject drugs (PWID), highlight the benefits of cure for the individual patient, and discuss the importance of simplified and decentralized care and how it can be adapted to a variety of settings to reach marginalized patient groups.
Speaker
MD Brian Conway
Medical Director and President
Vancouver Infectious Diseases Centre
Chairperson
Biography
Medical Director at the Vancouver Infectious Diseases Centre (VIDC), and Adjunct Professor in the Faculty of Health Sciences, Simon Fraser University, Canada.
Professor Conway is an infectious diseases specialist involved in the design and evaluation of systems of care for inner city populations living with HIV & HCV, including the innovative community pop-up clinics, CPs. He has designed and directed over 25 clinical trials in this field.
MD Brian Conway
Medical Director and President
Vancouver Infectious Diseases Centre
Prioritizing HCV treatment for PWID in a peri/post-COVID world and its patient-level impact
Biography
Medical Director at the Vancouver Infectious Diseases Centre (VIDC), and Adjunct Professor in the Faculty of Health Sciences, Simon Fraser University, Canada.
Professor Conway is an infectious diseases specialist involved in the design and evaluation of systems of care for inner city populations living with HIV & HCV, including the innovative community pop-up clinics, CPs. He has designed and directed over 25 clinical trials in this field.
MD Brian Conway
Medical Director and President
Vancouver Infectious Diseases Centre
Welcome and Introduction
Biography
Medical Director at the Vancouver Infectious Diseases Centre (VIDC), and Adjunct Professor in the Faculty of Health Sciences, Simon Fraser University, Canada.
Professor Conway is an infectious diseases specialist involved in the design and evaluation of systems of care for inner city populations living with HIV & HCV, including the innovative community pop-up clinics, CPs. He has designed and directed over 25 clinical trials in this field.
Ms Jody Gilmore
Consultant for Health Federation of Philadelphia, PA
Health Federation of Philadelphia
Engaging the disengaged: Extending HCV care into prisons
1:30 PM - 1:40 PMBiography
Medical Director, Prevention Point Philadelphia, USA.
Ms. Gilmore has many years of experience caring for people living with HIV and Viral Hepatitis.
As the Medical Director of Prevention Point Philadelphia, she oversees the delivery of services for PWID, by providing co-location of such services as syringe exchange, MOUD, testing and treatment for HIV and viral hepatitis. She also serves as an advisory board consultant for AbbVie.
Professor Andrew L Lloyd
Professor
The Kirby Institute, University of New South Wales
Engaging the disengaged: Extending HCV care into prisons
1:40 PM - 1:50 PMBiography
Infectious Diseases physician and the Head of the Viral Immunology Systems Program (VISP) in the Kirby Institute, Australia.
Professor Lloyd is Chair of the INHSU prisons group and was awarded an Australia Medal for the provision of hepatitis services in prisons. His research includes cohort studies and implementation studies exploring HCV and its treatment in the prison setting. He has presented extensively on HCV elimination strategies in Australian prisons.
Chair - will not appear in Portal
Brian Conway
Medical Director and President
Vancouver Infectious Diseases Centre
Speaker - will not appear in Portal
Jody Gilmore
Consultant for Health Federation of Philadelphia, PA
Health Federation of Philadelphia
Andrew L Lloyd
Professor
The Kirby Institute, University of New South Wales
Support Staff
Alyssa Koenigsberg
Fishawack
Matthew Krzywosz
Associate Scientific Director /assistant Medical Director-hcv
Abbvie, Inc.
